Phreesia, Inc. (NYSE:PHR – Get Free Report) shares hit a new 52-week low on Friday after Canaccord Genuity Group lowered their price target on the stock from $46.00 to $43.00. Canaccord Genuity Group currently has a buy rating on the stock. Phreesia traded as low as $21.46 and last traded at $21.50, with a volume of 197686 shares trading hands. The stock had previously closed at $23.64.
Other equities analysts have also issued research reports about the stock. Robert W. Baird reduced their target price on shares of Phreesia from $40.00 to $39.00 in a report on Thursday. Citigroup decreased their target price on Phreesia from $40.00 to $37.00 and set a “buy” rating for the company in a research report on Thursday. Royal Bank of Canada dropped their target price on Phreesia from $33.00 to $29.00 and set a “sector perform” rating on the stock in a report on Thursday. Needham & Company LLC reissued a “buy” rating and set a $40.00 price target on shares of Phreesia in a research report on Thursday. Finally, Stephens reaffirmed an “overweight” rating and issued a $37.00 price objective on shares of Phreesia in a research report on Thursday. Two investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $38.00.
Insider Buying and Selling
In related news, SVP Michael J. Davidoff sold 1,075 shares of Phreesia stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $31.75, for a total value of $34,131.25. Following the completion of the transaction, the senior vice president now directly owns 93,576 shares in the company, valued at $2,971,038. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 5.80% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of PHR. HRT Financial LP bought a new position in Phreesia during the 4th quarter worth $1,334,000. ExodusPoint Capital Management LP bought a new position in shares of Phreesia during the first quarter worth about $1,183,000. Credit Suisse AG increased its holdings in shares of Phreesia by 2.6% in the 4th quarter. Credit Suisse AG now owns 2,028,346 shares of the company’s stock worth $65,637,000 after acquiring an additional 50,827 shares during the period. Brown Advisory Inc. lifted its position in Phreesia by 4.2% in the 1st quarter. Brown Advisory Inc. now owns 3,227,530 shares of the company’s stock valued at $104,217,000 after purchasing an additional 130,622 shares during the last quarter. Finally, Moody National Bank Trust Division boosted its stake in Phreesia by 189.5% during the 1st quarter. Moody National Bank Trust Division now owns 45,500 shares of the company’s stock valued at $1,469,000 after purchasing an additional 29,782 shares during the period. 94.37% of the stock is currently owned by institutional investors.
Phreesia Trading Down 8.2 %
The firm’s 50-day simple moving average is $29.53 and its 200 day simple moving average is $31.35. The stock has a market cap of $1.16 billion, a P/E ratio of -7.58 and a beta of 0.63. The company has a current ratio of 2.89, a quick ratio of 2.89 and a debt-to-equity ratio of 0.03.
Phreesia (NYSE:PHR – Get Free Report) last issued its quarterly earnings data on Wednesday, September 6th. The company reported ($0.68) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.71) by $0.03. The business had revenue of $85.80 million during the quarter, compared to analyst estimates of $85.26 million. Phreesia had a negative return on equity of 52.47% and a negative net margin of 47.75%. The business’s revenue for the quarter was up 26.4% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.89) EPS. As a group, equities research analysts anticipate that Phreesia, Inc. will post -2.69 earnings per share for the current year.
About Phreesia
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.